drugset / Trial / NCT05035654

LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)

NCT05035654

Phase 2 Completed 48 enrolled Lyra Therapeutics
RandomizedParallel-groupSingle-blindTreatment

Summary

This study will assess the safety, tolerability, pharmacokinetics and efficacy of two LYR-220 designs in symptomatic adult chronic rhinosinusitis (CRS) subjects who have had a prior functional endoscopic sinus surgery.

Timeline

Start
2021-11-23
Primary completion
2023-08-30
Completion
2023-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 7500 ug Other